The Microbiological Spectrum in Acute Dacryocystitis

This study has been completed.
Sponsor:
Information provided by:
Singapore National Eye Centre
ClinicalTrials.gov Identifier:
NCT00349297
First received: July 5, 2006
Last updated: May 11, 2010
Last verified: May 2010
  Purpose

Acute dacryocystitis in adults can be a very painful disease and may not respond well to medical therapy.

The purpose of this prospective non-randomised study is to determine the microorganisms causing acute dacryocystitis and the antibiotic sensitivities of these organisms.

The study also aims to correlate the microbiological findings to the severity of clinical manifestations and evaluate the effectiveness of our current practice of aspiration and empiric systemic antibiotic therapy in treating patients with acute dacryocystitis and hence review whether there is a need to alter current management strategy.


Condition
Dacryocystitis

Study Type: Observational
Study Design: Time Perspective: Prospective

Further study details as provided by Singapore National Eye Centre:

Study Start Date: November 2003
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Acute dacryocystitis patients

Criteria

INCLUSION CRITERIA:

  • Painful localised fluctuant induration just inferior to the medial canthal tendon of less than 2 weeks duration.

EXCLUSION CRITERIA:

  • Non-fluctuant lacrimal sac swelling
  • Uncooperative patient
  • Unwilling Patient
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00349297

Locations
Singapore
Singapore National Eye Centre
Singapore, Singapore, 168751
Sponsors and Collaborators
Singapore National Eye Centre
Investigators
Principal Investigator: Anshu Arundhati, MRCSED, MMED Singapore National Eye Centre
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00349297     History of Changes
Other Study ID Numbers: R325/18/2003
Study First Received: July 5, 2006
Last Updated: May 11, 2010
Health Authority: Singapore: Health Sciences Authority

Additional relevant MeSH terms:
Dacryocystitis
Lacrimal Apparatus Diseases
Eye Diseases

ClinicalTrials.gov processed this record on July 22, 2014